164 related articles for article (PubMed ID: 29270806)
1. Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver.
Nejabat M; Riegler T; Reitinger T; Subosits S; Römer M; Eichner J; Bilban M; Zell A; Huber WW; Schulte-Hermann R; Grasl-Kraupp B
Arch Toxicol; 2018 Feb; 92(2):953-966. PubMed ID: 29270806
[TBL] [Abstract][Full Text] [Related]
2. Proinflammatory mesenchymal effects of the non-genotoxic hepatocarcinogen phenobarbital: a novel mechanism of antiapoptosis and tumor promotion.
Riegler T; Nejabat M; Eichner J; Stiebellehner M; Subosits S; Bilban M; Zell A; Huber WW; Schulte-Hermann R; Grasl-Kraupp B
Carcinogenesis; 2015 Dec; 36(12):1521-30. PubMed ID: 26378027
[TBL] [Abstract][Full Text] [Related]
3. Differentiated and non-differentiated HepaRG™ cells: A possible in-vitro model system for early hepatocarcinogenesis and non-genotoxic carcinogens.
Gutmann M; Stimpfl E; Langmann G; Koudelka H; Mir-Karner B; Grasl-Kraupp B
Toxicol Lett; 2023 Dec; 390():15-24. PubMed ID: 37890683
[TBL] [Abstract][Full Text] [Related]
4. Cyproterone acetate induces DNA damage in cultured rat hepatocytes and preferentially stimulates DNA synthesis in gamma-glutamyltranspeptidase-positive cells.
Neumann I; Thierau D; Andrae U; Greim H; Schwarz LR
Carcinogenesis; 1992 Mar; 13(3):373-8. PubMed ID: 1347714
[TBL] [Abstract][Full Text] [Related]
5. Long term phenobarbital administration does not promote the multiplication of hepatocytes replicating after single cyproterone acetate administration.
Pichard V; Ferry N
Life Sci; 2005 May; 76(26):3057-68. PubMed ID: 15850598
[TBL] [Abstract][Full Text] [Related]
6. Non-genotoxic hepatocarcinogens stimulate DNA synthesis and their withdrawal induces apoptosis, but in different hepatocyte populations.
Roberts RA; Soames AR; Gill JH; James NH; Wheeldon EB
Carcinogenesis; 1995 Aug; 16(8):1693-8. PubMed ID: 7634391
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of DNA synthesis by phenobarbital in primary cultures of hepatocytes from normal rat liver and from hepatic nodules.
Manjeshwar S; Rao PM; Rajalakshmi S; Sarma DS
Carcinogenesis; 1992 Dec; 13(12):2287-91. PubMed ID: 1473236
[TBL] [Abstract][Full Text] [Related]
8. Dose dependence of phenobarbital promotion of preneoplastic hepatic lesions in F344 rats and B6C3F1 mice: effects on DNA synthesis and apoptosis.
Kolaja KL; Stevenson DE; Walborg EF; Klaunig JE
Carcinogenesis; 1996 May; 17(5):947-54. PubMed ID: 8640942
[TBL] [Abstract][Full Text] [Related]
9. Formation of DNA adducts by cyproterone acetate and some structural analogues in primary cultures of human hepatocytes.
Werner S; Kunz S; Beckurts T; Heidecke CD; Wolff T; Schwarz LR
Mutat Res; 1997 Dec; 395(2-3):179-87. PubMed ID: 9465929
[TBL] [Abstract][Full Text] [Related]
10. Dosing-induced stress causes hepatocyte apoptosis in rats primed by the rodent nongenotoxic hepatocarcinogen cyproterone acetate.
Roberts RA; Soames AR; James NH; Gill JH; Wheeldon EB
Toxicol Appl Pharmacol; 1995 Dec; 135(2):192-9. PubMed ID: 8545827
[TBL] [Abstract][Full Text] [Related]
11. Cyproterone acetate: a genotoxic carcinogen?
Kasper P
Pharmacol Toxicol; 2001 May; 88(5):223-31. PubMed ID: 11393581
[TBL] [Abstract][Full Text] [Related]
12. Sex-specific induction of apoptosis by cyproterone acetate in primary rat hepatocytes.
Kasper P; Mueller L
Carcinogenesis; 1999 Nov; 20(11):2185-8. PubMed ID: 10545424
[TBL] [Abstract][Full Text] [Related]
13. Effect of three tumour promoters on the stability of hepatocyte cultures and apoptosis after transforming growth factor-beta 1.
Oberhammer FA; Qin HM
Carcinogenesis; 1995 Jun; 16(6):1363-71. PubMed ID: 7788856
[TBL] [Abstract][Full Text] [Related]
14. DNA-damaging activity of the cyproterone acetate analogues chlormadinone acetate and megestrol acetate in rat liver.
Topinka J; Binkova B; Zhu HK; Andrae U; Neumann I; Schwarz LR; Werner S; Wolff T
Carcinogenesis; 1995 Jul; 16(7):1483-7. PubMed ID: 7542174
[TBL] [Abstract][Full Text] [Related]
15. DNA repair synthesis and DNA fragmentation in primary cultures of human and rat hepatocytes exposed to cyproterone acetate.
Martelli A; Mattioli F; Fazio S; Andrae U; Brambilla G
Carcinogenesis; 1995 Jun; 16(6):1265-9. PubMed ID: 7788841
[TBL] [Abstract][Full Text] [Related]
16. Controlled death (apoptosis) of normal and putative preneoplastic cells in rat liver following withdrawal of tumor promoters.
Bursch W; Lauer B; Timmermann-Trosiener I; Barthel G; Schuppler J; Schulte-Hermann R
Carcinogenesis; 1984 Apr; 5(4):453-8. PubMed ID: 6231134
[TBL] [Abstract][Full Text] [Related]
17. Determination of the length of the histological stages of apoptosis in normal liver and in altered hepatic foci of rats.
Bursch W; Paffe S; Putz B; Barthel G; Schulte-Hermann R
Carcinogenesis; 1990 May; 11(5):847-53. PubMed ID: 2139818
[TBL] [Abstract][Full Text] [Related]
18. HB-EGF is a paracrine growth stimulator for early tumor prestages in inflammation-associated hepatocarcinogenesis.
Sagmeister S; Drucker C; Losert A; Grusch M; Daryabeigi A; Parzefall W; Rohr-Udilova N; Bichler C; Smedsrød B; Kandioler D; Grünberger T; Wrba F; Schulte-Hermann R; Grasl-Kraupp B
J Hepatol; 2008 Dec; 49(6):955-64. PubMed ID: 18929421
[TBL] [Abstract][Full Text] [Related]
19. DNA synthesis, apoptosis, and phenotypic expression as determinants of growth of altered foci in rat liver during phenobarbital promotion.
Schulte-Hermann R; Timmermann-Trosiener I; Barthel G; Bursch W
Cancer Res; 1990 Aug; 50(16):5127-35. PubMed ID: 2379175
[TBL] [Abstract][Full Text] [Related]
20. Lack of promoting effects of phenobarbital at low dose on diethylnitrosamine-induced hepatocarcinogenesis in TGF-alpha transgenic mice.
Puatanachokchai R; Kakuni M; Wanibuchi H; Kinoshita A; Kang JS; Salim EI; Morimura K; Tamano S; Merlino GT; Fukushima S
Asian Pac J Cancer Prev; 2006; 7(2):274-8. PubMed ID: 16839222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
